Elena Cantone | Medicine and Dentistry | Research Excellence Award

Published on by Book of Award

Prof. Dr. Elena Cantone | Medicine and Dentistry | Research Excellence Award

University of Calabria | Italy

Prof. Dr. Elena Cantone is a highly accomplished researcher in the field of otorhinolaryngology, with a strong and sustained impact on clinical and translational research. Her scholarly output comprises 126 peer-reviewed documents, which together have received 1,953 citations from 1,649 citing documents, reflecting wide international recognition of her work. She maintains an h-index of 25, underscoring both the productivity and consistent influence of her research contributions. Her publications address key topics in chronic rhinosinusitis with nasal polyps (CRSwNP), severe asthma comorbidities, cystic fibrosis–related ENT manifestations, nasal cytology, biologic therapies, and multidisciplinary management strategies. She has played a significant role in advancing real-world evidence on biologic treatments such as dupilumab and mepolizumab, contributing to clinical guidelines, composite severity scoring systems, and long-term outcome assessments. Her research is frequently published in high-impact international journals including Allergy, Clinical Otolaryngology, Journal of Clinical Medicine, Journal of Cystic Fibrosis, The Laryngoscope, and Current Allergy and Asthma Reports. Through collaborative, multicenter studies and clinically driven investigations, her work continues to shape evidence-based practice and improve understanding of inflammatory and airway diseases at both national and international levels.

 

Citation Metrics (Scopus)

2000
1500
1000
500
0

Citations
1,953

h-index
25

Documents
126

Citations

h-index

Documents


View Scopus Profile

Featured Publications

Marcel Brown | Medicine and Dentistry | Research Excellence Award

Published on by Book of Award

Dr. Marcel Brown | Medicine and Dentistry | Research Excellence Award

Atrium Health Wake Forest Baptist | United States

Dr. Marcel Brown is a clinician–scientist whose research portfolio integrates orthopaedic surgery, regenerative medicine, translational molecular science, and cardiovascular physiology, with a strong emphasis on clinically impactful, mechanism-driven investigation. His scholarly output comprises 7 peer-reviewed documents, which have collectively received 145 citations, reflecting an h-index of 3, indicative of consistent citation impact across his publications. His research experience spans advanced orthopaedic outcomes research, musculoskeletal infection prevention, stem cell and acellular biologic therapies for osteoarthritis and post-traumatic osteoarthritis, and translational studies evaluating tissue regeneration, inflammation, and functional recovery using in vitro, in vivo, and ex vivo models. Complementing this work, he has contributed substantially to cardiovascular and exercise physiology research, including investigations into exercise-induced cardiac remodeling, pulmonary vascular disease, metabolic and hormonal responses to physical stress, and molecular mechanisms underlying maladaptive vascular fibrosis. His interdisciplinary collaborations have resulted in publications across high-impact journals in orthopaedics, translational medicine, cardiovascular science, and cell biology, including original research articles, systematic analyses, and clinically relevant case reports. Collectively, his research demonstrates a sustained commitment to bridging basic science with clinical application, advancing evidence-based surgical practice, regenerative strategies, and cardiometabolic health through rigorously designed translational and outcomes-focused studies.

 

Citation Metrics (Scopus)

150120

90

60

30

0

Citations
145

Documents
7

h-index
3

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Risk factors for failure after lumbar tubular microdecompression without stabilization
– Journal of the American Academy of Orthopaedic Surgeons, 2025

Harvey White | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Harvey White | Medicine and Dentistry | Best Researcher Award

Health New Zealand - The Health Network | New Zealand

Author Profile

Scopus

Orcid 

Early Academic Pursuits

Prof. Harvey White’s journey into medicine began with a strong academic foundation that laid the groundwork for his pioneering career in cardiology. His advanced studies culminated in a Doctorate of Science from the University of Otago, where his thesis explored the prognostic importance of cardiac volume and vessel patency in the context of thrombolytic therapy. This formative academic phase instilled in him both a scientific curiosity and a commitment to evidence-based medicine, shaping the direction of his future clinical and research endeavors.

Professional Endeavors

Over the decades, Prof. White has held leading positions in cardiology, serving as a cardiologist and Director of the Cardiovascular Research Unit at Auckland City Hospital, while also contributing as an Honorary Clinical Professor at the University of Auckland. His clinical practice has been marked by a dedication to advancing the treatment of acute coronary syndromes, dyslipidemia, and cardiovascular diseases in the elderly. Beyond hospital walls, his advocacy for patient-centered care and public health initiatives has reinforced his reputation as both a clinician and a community leader.

Contributions and Research Focus

Prof. White has made remarkable contributions in areas such as antithrombotic therapy, the universal definition of myocardial infarction, and biomarker development for acute coronary syndromes. His investigations into lipid-lowering therapies, genetic markers, and cardiovascular outcomes have influenced guidelines and shaped clinical practice worldwide. He has consistently emphasized the integration of clinical trials, translational research, and collaborative studies, ensuring that his findings benefit both scientific communities and patients directly.

Accolades and Recognition

A highly cited researcher, Prof. White’s prolific publication record—spanning books, book chapters, peer-reviewed articles, and clinical guidelines—has earned him recognition among the world’s most influential scientific minds. He has been honored with prestigious awards, including the Prince Mahidol Award for Medicine, fellowship titles from leading cardiology societies, and multiple recognitions for his research excellence and thought leadership. His standing among the top global experts in cardiology reflects not only his scholarly output but also his enduring influence on international medicine.

Impact and Influence

The global impact of Prof. White’s work is evident in both academia and clinical practice. His leadership in redefining myocardial infarction classifications has guided generations of cardiologists, while his advocacy for evidence-based practices has transformed patient care protocols. His influence extends to policy, having advised the World Health Organization on cardiovascular disease prevention and diabetes management in developing nations. As a mentor and educator, he has inspired countless medical professionals to pursue excellence in research and practice.

Legacy and Future Contributions

Prof. White’s legacy is firmly established in the annals of cardiovascular medicine, yet his ongoing contributions suggest that his influence is far from complete. His continuous research into emerging therapies, his role in international collaborations, and his commitment to bridging scientific advancements with real-world healthcare challenges ensure that his impact will continue to grow. By championing innovation while prioritizing patient welfare, he sets a standard for the future of cardiology.

Publications

Article: Use of coronary artery bypass graft surgery and percutaneous coronary intervention and associated outcomes in the ISCHEMIA trial
Authors: Harvey D. White, Sean M. O’Brien, William E. Boden, Stephen E. Fremes, Sripal Bangalore, Harmony R. Reynolds, Gregg W. Stone, Ziad A. Ali, Neeraj Parakh, Jose Luis Lopez-Sendon, et al.
Journal: American Heart Journal
Year: 2025

Article: Great Debate: the universal definition of myocardial infarction is flawed and should be put to rest
Authors: Juan-Carlos Kaski, Christian Mueller, Harvey White, Pedro Lopez-Ayala, Ranil de Silva
Journal: European Heart Journal (Other publication type)
Year: 2025

Article: Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial
Authors: C. Michael Gibson, Danielle Duffy, Maria Cecilia Bahit, Gerald Chi, Harvey White, Serge Korjian, John H. Alexander, A. Michael Lincoff, Mark Heise, Bronwyn A. Kingwell, et al.
Journal: European Heart Journal
Year: 2024

Article: Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial
Authors: Andrew P. DeFilippis, J. Dawn Abbott, Brandon M. Herbert, Marnie H. Bertolet, Bernard R. Chaitman, Harvey D. White, Andrew M. Goldsweig, Tamar S. Polonsky, Rajesh Gupta, Caroline Alsweiler, et al.
Journal: Circulation
Year: 2024

Article: Intracoronary thrombolysis in ST-elevation myocardial infarction: a systematic review and meta-analysis
Authors: Rajan Rehan, Sohaib Virk, Christopher C. Y. Wong, Freda Passam, Jamie Layland, Anthony Keech, Andy Yong, Harvey D. White, William Fearon, Martin Ng
Journal: Heart
Year: 2024

Conclusion

Prof. White’s biography is a testament to the profound difference that one individual can make in shaping modern medicine. His achievements reflect not only a personal dedication to research and patient care but also a broader vision for global cardiovascular health. His legacy, defined by innovation, leadership, and compassion, will inspire future generations of clinicians and researchers to carry forward the mission of improving lives through science and medicine.

Armin Arshi | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Armin Arshi | Medicine and Dentistry | Best Researcher Award

NYU Langone Health | United States

Author Profile

Scopus

Google Scholar

🌱 Early Academic Pursuits

Dr. Armin Arshi began his academic journey with distinction, graduating Summa Cum Laude with a Bachelor of Science in Bioengineering from UCLA in 2012. He complemented his technical depth with a specialization in Materials Science and Engineering. Driven by a passion for medicine and innovation, he pursued his Doctor of Medicine at the David Geffen School of Medicine at UCLA, earning membership in the prestigious Alpha Omega Alpha (AΩA) Honor Medical Society and receiving multiple academic awards for excellence in research and leadership.

🏥 Professional Endeavors

Following medical school, Dr. Arshi underwent rigorous Orthopaedic Surgery residency training at UCLA, where he served as Administrative Chief Resident. He then pursued a Fellowship in Adult Reconstruction at the Rothman Orthopaedic Institute, a globally respected hub for joint replacement. His clinical career has included prominent roles as Attending Orthopaedic Surgeon at NYU Langone Health and currently at Beach Orthopaedic Specialty Institute and UCI Health in California. As an Assistant Professor at NYU Grossman School of Medicine, he has shaped orthopedic education and research.

🔬 Contributions and Research Focus

Dr. Arshi’s research spans joint arthroplasty, surgical outcomes, infection control, and implant biomechanics. He has authored numerous peer-reviewed publications in elite journals like The Journal of Arthroplasty and Arthroplasty Today, addressing topics from patient follow-up to periprosthetic joint infection and predictive modeling. His innovative studies have earned recognition at prestigious meetings including AAOS, NASS, and Western Orthopaedic Association. He has also contributed to surgical literature through influential book chapters and national guidelines.

🏅 Accolades and Recognition

Dr. Arshi’s excellence has been honored with the Stafford L. Warren Medal (UCLA’s highest medical school award), numerous resident research awards, and national research prizes, including the NIH DEBUT Competition and Howard Hughes Fellowships. His leadership in orthopedics is further affirmed through roles on editorial boards of major journals and review panels, demonstrating both scientific rigor and peer respect.

🌍 Impact and Influence

With a keen focus on evidence-based medicine, Dr. Arshi’s work has impacted clinical decision-making in joint replacement, particularly in VTE prophylaxis, return-to-sport protocols, and implant longevity. His efforts to understand disparities in patient outcomes and enhance surgical education have made significant strides in advancing personalized orthopedic care. He is a thought leader committed to improving both technical standards and patient experiences.

🔮 Legacy and Future Contributions

Poised at the intersection of clinical mastery and academic excellence, Dr. Arshi is a rising force in orthopaedics. His commitment to innovation, mentorship, and multidisciplinary collaboration positions him to be a lasting influence in orthopedic surgery and medical education. As he continues to lead in surgery, research, and institutional quality initiatives, his legacy will shape the next generation of joint reconstruction techniques and orthopedic leaders.

Publications

📄 Patient characteristics associated with loss to follow-up after total joint arthroplasty
• Authors: Ruff G, Sarfraz A, Lawrence KW, Arshi A, Rozell JC, Schwarzkopf R
• Journal: Journal of Arthroplasty
• Year: 2025

📄 Risk of early manipulation in cemented versus cementless total knee arthroplasty: analysis of the American Joint Replacement Registry
• Authors: Schaffler B, Zaniletti I, Arshi A, De M, Schwarzkopf R, Rozell JC
• Journal: Journal of Arthroplasty
• Year: 2025

📄 Why do total joint arthroplasties get canceled on the day of surgery?
• Authors: Sandoval CG, Katzman JL, Connolly P, Grossman EL, Arshi A, Schwarzkopf R
• Journal: Journal of Arthroplasty
• Year: 2025

📄 Total joint arthroplasty patients from distressed communities return to sports and physical activities at lower rates
• Authors: Cozzarelli NF, Khan IA, Arshi A, Sherman MB, Fillingham YA
• Journal: Journal of Arthroplasty
• Year: 2025

📄 Aseptic tibial loosening is associated with thickness of the cement: a radiographic case-control study
• Authors: Schaffler B, Robin JX, Katzman J, Arshi A, Rozell JC, Schwarzkopf R
• Journal: Journal of Arthroplasty
• Year: 2024

Hangyu Gu | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Hangyu Gu | Medicine and Dentistry | Best Researcher Award

Beijing Jishuitan Hospital | China

Author Profile

Orcid

🎓 Early Academic Pursuits

Dr. Hangyu Gu embarked on his journey in medicine at the prestigious Peking University, where he earned his Bachelor’s Degree in Medicine between September 2004 and July 2010. Demonstrating a clear commitment to clinical excellence, he pursued further specialization and obtained his Medical Doctor’s Degree from the same institution by July 2012. His early academic years laid a strong foundation in medical science and surgical disciplines, setting the tone for a career deeply rooted in evidence-based practice and patient-centered care.

🏥 Professional Endeavors

Dr. Gu began his clinical practice as an intern at the No.2 Affiliated Hospital of Peking University from March 2010 to July 2011. He quickly advanced to become a resident in surgery at the same hospital, gaining invaluable experience in surgical protocols and trauma care. From August 2012 to April 2018, he served as an orthopedic fellow at the renowned Beijing Jishuitan Hospital, affiliated with Peking University’s Fourth Medical College. Since May 2018, he has been serving as an attending physician in the Department of Orthopedics and Traumatology at the same institution, where his clinical and surgical expertise continues to grow.

🔬 Contributions and Research Focus

Dr. Gu’s research interests focus primarily on orthopedic surgery, trauma recovery, and post-surgical outcomes in elderly patients. In 2022, he co-authored a study titled “Combination of Cable Cerclage and Hook Plate for the Fixation of Comminuted Fractures of Inferior Patellar Pole,” published in Orthopaedic Surgery, which reviewed the outcomes of 16 patients followed up for a year. In 2023, he contributed to groundbreaking research on femoral neck fractures, identifying how complete posterior cortex fractures increase the risk of avascular necrosis in elderly patients—published in the Chinese Medical Journal.

🏆 Accolades and Recognition

While formal awards are not listed, Dr. Gu's continuous appointment and academic contributions at one of China's top orthopedic institutions speak volumes about his professional esteem and peer recognition. His publication in internationally recognized journals reflects the impact and credibility of his research within the orthopedic community.

🌍 Impact and Influence

Dr. Gu's work significantly influences clinical decisions in orthopedic trauma management, especially for aging populations—a demographic increasingly prone to hip and knee fractures. His research contributes to improved surgical techniques and enhanced patient outcomes, guiding surgeons worldwide in managing complex cases with precision and care.

🔮 Legacy and Future Contributions

With an impressive blend of clinical experience and academic rigor, Dr. Hangyu Gu is poised to make lasting contributions to orthopedic innovation and surgical education. As he continues to publish and mentor, his influence will likely shape future best practices in fracture fixation and geriatric trauma care, advancing both national and global orthopedic standards.

Publications

📝 A Comparative Finite Element Study of Novel Design Hook Plates for Fixation of Patella Fracture

Authors: Cunxiang Ma, Jingyu Pan, Teng Zhang, Junqiang Wang, Wei Han, Hangyu Gu
Journal: Injury
Year: 2025

📝 Combination of Cable Cerclage and Hook Plate for the Fixation of Comminuted Fractures of Inferior Patellar Pole: A Review of 16 Consecutive Patients Followed Up for a Minimum of 1 Year

Authors: Hangyu Gu, Shiwen Zhu, Ting Li, Xinbao Wu
Journal: Orthopaedic Surgery
Year: 2022

📝 Complete Fracture of Posterior Cortex Increases the Risk of Avascular Necrosis After Osteosynthesis for Non-Displaced Femoral Neck Fractures in Elderly Patients

Authors: Hangyu Gu, Qianqian Wang, Minghui Yang, Xinbao Wu, Faming Tian, Shiwen Zhu
Journal: Chinese Medical Journal
Year: 2023

Yoshiya Tanaka | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Yoshiya Tanaka | Medicine and Dentistry | Best Researcher Award

University of Occupational and Environmental Health | Japan

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Prof. Yoshiya Tanaka embarked on his academic journey at the University of Occupational and Environmental Health, Japan (UOEH), where he earned his MD in 1984. His thirst for knowledge and commitment to medical research led him to pursue a PhD at the Graduate School of Medical Science, UOEH, which he completed in 1988. This strong academic foundation laid the groundwork for his exceptional career in internal medicine and rheumatology.

🌟 Professional Endeavors

Prof. Tanaka’s illustrious career began with a prestigious opportunity as a Visiting Fellow in the Experimental Immunology Branch at the National Cancer Institute, NIH, USA, from 1989 to 1992. Upon returning to Japan, he rapidly ascended the academic ladder, becoming a Professor and Chairman of the First Department of Internal Medicine at UOEH in 2000. His leadership and expertise earned him the role of Dean of the Graduate School of Medical Science at UOEH in 2017, followed by his appointment as Director of the International Center at UOEH in 2022.

🔬 Contributions and Research Focus

Prof. Tanaka has dedicated his career to advancing the field of rheumatology, clinical immunology, and inflammatory diseases. His research primarily focuses on rheumatoid arthritis, systemic lupus erythematosus, and novel therapeutic approaches, including Janus kinase (JAK) inhibitors and biologic therapies. His groundbreaking work on cytokine-targeting therapies has significantly influenced treatment strategies for autoimmune diseases. As a key member of multiple scientific societies, he has contributed to the Japanese College of Rheumatology (JCR), the Japanese Society of Clinical Immunology, and the Asia Pacific League of Associations for Rheumatology (APLAR). His editorial contributions include serving as an editor or associate editor for prestigious journals such as The Lancet Rheumatology, Annals of Rheumatic Diseases, and Arthritis Research & Therapy.

🏆 Accolades and Recognition

Prof. Tanaka's contributions to rheumatology and immunology have been recognized through numerous awards. In 2003, he received the Academic Award from the Japanese Society of Bone and Mineral Research (JSBMR), followed by the President Award from the Japanese College of Rheumatology in 2008. His outstanding research was acknowledged globally when he was honored with the Congress Award from the European Alliance of Associations for Rheumatology (EULAR) in 2009. In 2023, his lifelong contributions earned him the prestigious Honorary Award from EULAR.

🔍 Impact and Influence

With over 1,067 publications in English and an impressive h-index of 117, Prof. Tanaka's research has left an indelible mark on the field of rheumatology. His total impact factor of 6,402 underscores the significance of his work in shaping clinical practices worldwide. His seminal studies, including those published in Nature, The New England Journal of Medicine, and The Lancet, have influenced treatment protocols and deepened the understanding of inflammatory and autoimmune diseases. As a mentor, he has guided numerous young researchers, fostering the next generation of scientists and clinicians in Japan and beyond. His involvement in international collaborations has further solidified his role as a global leader in rheumatology research.

🌱 Legacy and Future Contributions

Prof. Tanaka’s legacy is defined by his relentless pursuit of scientific discovery and his commitment to improving patient care. His work in cytokine-targeted therapies and JAK inhibitors has paved the way for more effective and personalized treatments for autoimmune diseases. As he continues to lead groundbreaking research and mentor future medical professionals, his impact on the field will endure for generations to come. With his ongoing roles at UOEH and leadership positions in international rheumatology organizations, Prof. Tanaka remains at the forefront of medical innovation. His future contributions promise to further revolutionize treatment paradigms and enhance the quality of life for patients worldwide.

 

Publications

  • Article: Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness
    Authors: S. Kubo, Y. Miyazaki, T. Nishino, S. Nakayamada, Y. Tanaka
    Journal: Annals of the Rheumatic Diseases
    Year: 2025

  • Article: Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study
    Authors: N. Okamoto, T.A. Atsumi, M. Takagi, Y. Tanaka, M. Kuwana
    Journal: Modern Rheumatology
    Year: 2025

  • Article: Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus
    Authors: Y. Fujita, S. Nakayamada, S. Kubo, H. Tanaka, Y. Tanaka
    Journal: RMD Open
    Year: 2025

  • Article: Time trends of variability in disease activity in systemic lupus erythematosus
    Authors: N. Li, A.Y.B. Hoi, S.F. Luo, R.K. Kandane-Rathnayake, E.F. Morand
    Journal: Lupus Science and Medicine
    Year: 2025

  • Article: The Uncoupling of Disease Activity from Joint Structural Progression in Patients with Rheumatoid Arthritis Treated with Filgotinib
    Authors: Y. Tanaka, T.A. Atsumi, D. Aletaha, C. Watson, T. Takeuchi
    Journal: Rheumatology and Therapy
    Year: 2025

 

Meilang Xue | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Assoc. Prof. Dr. Meilang Xue | Medicine and Dentistry | Best Researcher Award

University of Sydney | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 🎓

Assoc. Prof. Dr. Meilang Xue embarked on her academic journey with a strong passion for biomedical sciences. She earned her PhD from the University of New South Wales in 2002, laying the foundation for a distinguished career in molecular and cellular research. Her early academic years were marked by an inquisitive drive to uncover the intricate mechanisms of inflammatory and autoimmune diseases, setting the stage for groundbreaking discoveries in the field.

Professional Endeavors 🏢

Dr. Xue is currently the Head of the Sutton Arthritis Research Laboratory and the Chief Scientist of the A3BC Biobank at the Institute of Bone & Joint Research, Kolling Institute, University of Sydney. Since joining the Sutton Lab after her PhD, she has been instrumental in advancing the understanding of inflammatory and autoimmune diseases. Her leadership in these roles has facilitated significant research collaborations and the translation of scientific findings into potential therapeutic applications.

Contributions and Research Focus 🔬

Dr. Xue's research primarily explores the molecular and cellular mechanisms underpinning inflammatory and autoimmune conditions. She was the first to elucidate the critical role of the endothelial protein C receptor (EPCR) and its anti-clotting properties within the synovial joint and skin. These discoveries have revolutionized the understanding of rheumatoid arthritis, skin inflammation, and even type 1 diabetes. Her research has been widely recognized in high-impact journals such as Ann Rheum Dis, Arthritis Rheum, Rheumatology, and Journal of Investigative Dermatology. With 92 publications, 25 patents, and over 6,200 citations, her work has significantly contributed to medical science.

Accolades and Recognition 🏆

Dr. Xue's exemplary contributions have earned her numerous prestigious research fellowships and grants exceeding $5 million, funded by the NHMRC, Arthritis Australia, Lincoln Centre, JDRF International, and industry partners. She has been ranked as the 12th world-leading expert in endothelial protein C receptor research, placing her in the top 0.67% of published authors worldwide in this domain. Her h-index of 37 further underscores her influential impact on the field.

Impact and Influence 🌍

Beyond her research, Dr. Xue has played a crucial role in fostering the next generation of scientists. She has mentored and supervised numerous PhD candidates, postdoctoral fellows, honors students, and research assistants. As a committee member of the Kolling Institute’s Musculoskeletal Priority Research Area Leadership Group and the Kolling Research Enabler Group, she continues to shape the direction of musculoskeletal research. Additionally, her work with the A3BC as a Steering Committee member and chief scientist since 2017 has strengthened national and international research collaborations.

Legacy and Future Contributions 📚

Dr. Xue's dedication to scientific excellence ensures a lasting legacy in inflammatory and autoimmune disease research. Her ongoing studies into the protein C system’s role in disease modulation continue to inspire new therapeutic strategies. With her leadership in academia and industry collaborations, she is set to drive further advancements in precision medicine. Her unwavering commitment to research, mentorship, and innovation cements her reputation as a trailblazer in the field of molecular medicine.

Publications

  • 📄 Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis
    Author(s): Meilang Xue, Lyn March
    Journal: Cells
    Year: 2025

  • 📄 EPCR Deficiency Ameliorates Inflammatory Arthritis in Mice by Suppressing the Activation and Migration of T Cells and Dendritic Cells
    Author(s): Meilang Xue, Haiyan Lin, Hai Po Helena Liang, Christopher John Jackson, L. M. March
    Journal: Rheumatology (United Kingdom)
    Year: 2024

  • 📄 Exploring the Association Between Circulating Endothelial Protein C Receptor and Disease Activity of Rheumatoid Arthritis in a Pilot Study
    Author(s): Meilang Xue, Haiyan Lin, Tom Lynch, Mihir Dilip Wechalekar, L. M. March
    Journal: Rheumatology Advances in Practice
    Year: 2024

  • 📄 Endothelial Protein C Receptor and 3K3A-Activated Protein C Protect Mice from Allergic Contact Dermatitis in a Contact Hypersensitivity Model
    Author(s): Meilang Xue, Christopher John Jackson, Haiyan Lin, John H. Griffin, L. M. March
    Journal: International Journal of Molecular Sciences
    Year: 2024

  • 📄 Involvement of PAR-2 in the Induction of Cell-Specific Matrix Metalloproteinase-2 by Activated Protein C in Cutaneous Wound Healing
    Author(s): Sohel M. Julovi, Kelly J. McKelvey, Nikita Minhas, Meilang Xue, Christopher John Jackson
    Journal: International Journal of Molecular Sciences
    Year: 2024

 

Guoxin Ni | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Guoxin Ni | Medicine and Dentistry | Best Researcher Award

First Affiliated Hospital of Xiamen University | China

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Prof. Guoxin Ni embarked on his academic journey with a strong foundation in [specific field], earning his [degree] from [university] in [year]. His early years were marked by an insatiable curiosity and dedication to understanding [relevant subject], which laid the groundwork for his future contributions to academia and research.

🌟 Professional Endeavors

Over the years, Prof. Ni has been associated with esteemed institutions such as [institution names], where he has played a pivotal role in [teaching/research]. As a [current position] at [university/institution], he has been instrumental in shaping the academic landscape, mentoring students, and spearheading research initiatives that push the boundaries of [field of expertise].

🔬 Contributions and Research Focus

Prof. Ni’s research is centered on [key research areas], where he has made groundbreaking discoveries in [specific topic]. His work on [notable research or project] has been widely recognized, contributing significantly to the advancement of [industry/academic field]. His innovative approaches and methodologies have paved the way for new understandings and applications in [related domain].

🏆 Accolades and Recognition

A recipient of numerous awards, Prof. Ni’s excellence has been acknowledged through [list of notable awards and honors]. His contributions have been celebrated in [journals/conferences], and he continues to be a sought-after speaker and expert in his field.

🌐 Impact and Influence

Beyond academia, Prof. Ni has influenced the broader [industry/field] community through collaborations with [organizations/industries]. His work has inspired budding researchers and professionals alike, setting new benchmarks for innovation and excellence. His leadership in [specific initiative or research group] has fostered a culture of exploration and intellectual growth.

💪 Legacy and Future Contributions

Looking ahead, Prof. Ni remains committed to advancing research in [field], with ongoing projects aimed at [future research direction]. His vision and dedication continue to drive progress, ensuring a lasting legacy in both academic and professional circles. His impact will undoubtedly shape the future of [industry or field] for generations to come.

 

Publications

📄 Mechanosensitive lncRNA H19 promotes chondrocyte autophagy, but not pyroptosis, by targeting miR-148a in post-traumatic osteoarthritis
Authors: Xuchang Zhou, Hong Cao, Tao Liao, Shengyao Liu, Guoxin Ni
Journal: Non-coding RNA Research
Year: 2025

📄 Antioxidant taurine inhibits chondrocyte ferroptosis through upregulation of OGT/Gpx4 signaling in osteoarthritis induced by anterior cruciate ligament transection
Authors: Xuchang Zhou, Yajing Yang, Xu Qiu, Donghai Lin, Guoxin Ni
Journal: Journal of Advanced Research
Year: 2025

📄 Translation, Cross-Culture Adaptation and Measurement Properties of the Simplified Chinese Version of the Osteoarthritis Knowledge Scale
Authors: Ziru Wang, Ben Darlow, Huili Deng, Guoxin Ni
Journal: Musculoskeletal Care
Year: 2024

📄 Tetrathiomolybdate alleviates osteoporosis by activating the PI3K/AKT signaling axis
Authors: Xuchang Zhou, C.H. Cao, Dongxue Wang, Shengyao Liu, Guoxin Ni
Journal: European Cells and Materials
Year: 2024

📄 Evaluation of Quantitative and Selective Sensory Fiber Dysfunction in Patients with Cirrhosis
Authors: Nannan Zhang, Zhiyong Wang, Jianmin Chen, Guoxin Ni, Jun Ni
Journal: Current Neurovascular Research
Year: 2024

Jeong A Kim | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Jeong A Kim | Medicine and Dentistry | Best Researcher Award

St. Vincent Hospital, The Catholic University of Korea | South Korea

Author Profile

Scopus

Early Academic Pursuits ✨

Prof. Jeong A Kim embarked on an illustrious academic journey in the field of medicine, laying a solid foundation at the Catholic University Medical College. She completed her premedical course in 1986, followed by earning her Doctor of Medicine degree in 1990. Her passion for internal medicine and hematology led her to pursue advanced studies at The Catholic University of Korea, where she obtained a Master’s degree in 1998 and a Ph.D. in 2001. This strong academic background established her as a dedicated scholar committed to the advancement of medical sciences.

Professional Endeavors 🏥

Prof. Kim's professional career began with rigorous postdoctoral training. She completed her internship at St. Mary’s Hospital in 1991, followed by a residency in Internal Medicine at Catholic University Medical College until 1995. She further honed her expertise in hemato-oncology through a fellowship at Samsung Medical Center. Her international exposure expanded when she joined the Department of Microbiology and Immunology at IUPUI, USA, as a postdoctoral researcher. Her academic appointments at The Catholic University of Korea saw a steady rise, from Instructor in 1997 to Assistant Professor in 2001, Associate Professor in 2009, and finally attaining the prestigious title of Professor of Internal Medicine in 2014. In parallel, she has been a dedicated physician at St. Vincent Hospital since 1997 and has been leading the hematology and stem cell transplantation center since 2018.

Contributions and Research Focus 📝

Prof. Kim has made groundbreaking contributions in hematology and oncology, with a primary focus on stem cell transplantation, multiple myeloma, and lymphoma. Her extensive clinical trials and research studies have played a pivotal role in developing new treatment modalities for hematologic malignancies. Her work in targeted therapies, chemotherapy combinations, and immunotherapy has significantly improved patient outcomes and quality of life. She has been involved in more than 60 clinical trials, evaluating novel drug efficacy and safety, including studies on Zoledronic acid for multiple myeloma, targeted treatments like Dasatinib for leukemia, and the role of rituximab in lymphoma. Her research has also delved into prognostic factors, precision medicine, and innovative therapeutic strategies for refractory and relapsed hematologic diseases.

Accolades and Recognition 🏆

Prof. Kim's relentless pursuit of excellence has earned her recognition from esteemed medical institutions and societies. As a member of the Korean Association of Internal Medicine, the Korean Hematology Association, and the American Hematology Association, she has played an instrumental role in shaping global hematologic research. Her contributions have been acknowledged through numerous awards, invitations as a keynote speaker, and influential publications in high-impact medical journals.

Impact and Influence ✨

With a career spanning decades, Prof. Kim has mentored numerous young medical professionals, guiding them in clinical research and evidence-based medical practice. Her work has directly influenced hematologic treatment protocols in Korea and internationally. Her leadership in hematology and stem cell transplantation has set new benchmarks in patient care and innovative treatment approaches.

Legacy and Future Contributions 🌟

Prof. Jeong A Kim's legacy is deeply ingrained in the advancements of hematology and oncology. Her dedication to research, patient care, and education continues to inspire the next generation of medical professionals. Looking ahead, she remains committed to pioneering more targeted therapies, enhancing stem cell transplantation techniques, and improving long-term survival rates for hematologic malignancy patients. With ongoing research and collaborations, she is poised to make even greater strides in the field, leaving an indelible mark on medical science and patient care.

 

Publications

📄 The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma
Authors: H. Cho, J. Kim, Y. Park, Y. Kim, J. Kim, Jeong-ah
Journal: Leukemia Research
Year: 2025

📄 Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Authors: N.L. Bartlett, U.H. Hahn, W. Kim, F. Jie, J. Kim, Jeong-ah
Journal: Journal of Clinical Oncology
Year: 2025

📄 Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
Authors: D. Shin, S. Park, E. Jang, W. Lee, D. Kim
Journal: Leukemia Research
Year: 2024

📄 Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
Authors: H.Y. Yhim, Y. Park, J. Kim, Jeong-ah, D. Yang, J. Kwak
Journal: The Korean Journal of Internal Medicine
Year: 2024

Zhihan Zhu | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Ms. Zhihan Zhu | Medicine and Dentistry | Best Researcher Award

Department of Burn and Plastic Surgery, The First People’s Hospital of Changzhou | China

Author Profile

Scopus

🎓 Early Academic Pursuits

Ms. Zhihan Zhu pursued her Bachelor’s degree at Nantong University, focusing on Clinical Medicine with a specialization in oncology. Her academic excellence earned her scholarships for three consecutive years, reflecting her dedication and outstanding performance throughout her studies. For her Master’s studies, she specialized in Burn and Plastic Surgery at Nantong University’s Xinglin College. Her education also included robust foundational courses in internal medicine, surgery, obstetrics, pediatrics, pathology, and anatomy.

🏥 Professional Endeavors

Ms. Zhu gained substantial clinical experience through internships and residencies at renowned hospitals, including the Jiangsu Provincial Yangzhou Jiangdu People's Hospital and Shanghai Minhang District Oncology Hospital. She excelled in surgical operations, patient management, and medical communication. Her expertise spans advanced techniques like autologous skin grafting, deep vein catheterization, and burn wound management. She also possesses proficiency in clinical documentation, prescription optimization, and patient interaction.

🧪 Contributions and Research Focus

Ms. Zhu’s research focuses on wound healing, tissue regeneration, and therapeutic advancements. Her notable projects include:

  • Developing biomimetic nanoparticles for targeted drug delivery in burn treatment.
  • Exploring the protective effects of artemisinin derivatives on liver damage post-burn injury.
  • Investigating adipose-derived stem cells in scar regeneration.

Her work has led to multiple scholarly publications as a primary or co-author, contributing significantly to advancements in burn surgery and regenerative medicine.

🏆 Accolades and Recognition

Ms. Zhu’s academic journey is marked by numerous honors, including the Master's Research Scholarship at Nantong University for three consecutive years. Her research contributions have been recognized by peers in the scientific community, reflecting her dedication and impact.

🌍 Impact and Influence

Ms. Zhu’s work in innovative surgical techniques and regenerative therapies is improving patient outcomes in burn care. Her ability to integrate clinical expertise with cutting-edge research demonstrates her influence in shaping future medical practices in her field.

🌟 Legacy and Future Contributions

With her strong foundation in clinical medicine and pioneering research, Ms. Zhu is poised to leave a lasting legacy in burn and plastic surgery. Her commitment to academic excellence and patient care will undoubtedly lead to transformative advancements in medicine.

 

Publications

📝Chitooligosaccharides promote diabetic wound healing by mediating fibroblast proliferation and migration

  • Authors: Li, Z., Zhang, C., Wang, L., Zhou, Y., Zhang, Y.
  • Journal: Scientific Reports
  • Year: 2025,

📝Application of minimally invasive debridement for deep second-degree facial burns in the early postburn phase

  • Authors: Zhang, C., Li, Z., Zhang, Q., Hu, K., Zhang, Y.
  • Journal: BMC Surgery
  • Year: 2025

📝Biomimetic nanoparticles of platelet membranes carrying bFGF and VEGFA genes promote deep burn wound healing

  • Authors: Wang, B., Chen, J., Zhang, C., Zhang, Y., Jiang, Y.
  • Journal: International Immunopharmacology
  • Year: 2023

📝Effect of stem cell treatment on burn wounds: A systemic review and a meta-analysis

  • Authors: Qiao, Y., Zhang, Q., Peng, Y., Li, Z., Zhang, Y.
  • Journal: International Wound Journal
  • Year: 2023

📝Identification of nanoparticle-mediated siRNA-ASPN as a key gene target in the treatment of keloids

  • Authors: Dong, Y., Zhang, C., Zhang, Q., Gu, H., Zhang, Y.
  • Journal: Frontiers in Bioengineering and Biotechnology
  • Year: 2022